首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma.
【24h】

Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma.

机译:吡唑衍生物在肝细胞癌中作为潜在的多激酶抑制剂的设计,合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

We described the optimization, by molecular modelling, of small pyrazole derivatives, as kinase inhibitors, obtained through a 1,3-dipolar cycloaddition between nitrile imines and functionalized acetylenes. The two compounds, selected as potential agents active against hepatocellular carcinoma (HCC) were then evaluated in?vitro for their biological activity on HCC-derived cell lines. The compounds show a promising inhibitory growth efficacy (IC(50) 50-100?μM) in SNU449 cell line, as well as block of cell cycle progression and induction of apoptosis, and can be considered as lead compounds for further SAR developments.
机译:我们描述了通过分子建模优化的小吡唑衍生物,作为激酶抑制剂,是通过腈亚胺和官能化乙炔之间的1,3-偶极环加成反应获得的。然后,对这两种被选作对肝细胞癌(HCC)有活性的潜在药物进行体外评估,以评估它们对HCC衍生细胞系的生物学活性。这些化合物在SNU449细胞系中显示出有希望的抑制性生长功效(IC(50)50-100?μM),并能阻止细胞周期进程和诱导凋亡,因此可以认为是进一步发展SAR的先导化合物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号